Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple Myeloma
Clinical trial NCT01335685 · COMPLETED
Trial details
- NCT number
- NCT01335685
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-27
- Primary completion
- 2016-12-29
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.